🇺🇸 FDA
Patent

US 7067653

Porphyrin Based neuton capture agents for cancer therapy

granted A61KA61K41/0071A61K41/0095

Quick answer

US patent 7067653 (Porphyrin Based neuton capture agents for cancer therapy) held by The Regents of the University of California expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K41/0071, A61K41/0095, A61P, A61P35/00